Banking Law and Digital Identity in Healthcare Finance Spain

Introduction

Digital identity has become important in healthcare finance in Spain because hospitals, insurers, banks, fintech companies and public health authorities increasingly use electronic systems for medical payments, insurance claims, healthcare loans, reimbursement, payroll and medical financing. A patient may be identified through a national identity document, electronic certificate, health card, digital wallet, biometric system or strong customer-authentication method.

The legal difficulty is that healthcare-finance identity combines financial information with highly sensitive health data. A bank may need to verify a person’s identity and payment authority, but it normally should not receive unnecessary information about the person’s diagnosis or medical history.

Legal and Regulatory Framework

The General Data Protection Regulation classifies health information as special-category personal data. Its processing is permitted only under strict conditions, such as healthcare provision, public interest in public health, insurance administration or a legal obligation. The Spanish Organic Law 3/2018 supplements the GDPR and protects the constitutional right to control personal information under Article 18.4 of the Spanish Constitution.

The Spanish Law 41/2002 on patient autonomy and clinical information protects medical records, confidentiality and patient access rights. A bank financing surgery, medical treatment or insurance premium should receive only the information necessary for payment, eligibility or contractual administration. It should not obtain the complete clinical record merely because it is financing healthcare.

Law 6/2020 on electronic trust services operates together with the EU eIDAS Regulation. Electronic signatures, qualified certificates, electronic seals and trusted timestamps may be used to sign healthcare-finance contracts, insurance documents, medical-loan agreements and reimbursement instructions. A qualified electronic signature has a legal effect comparable to a handwritten signature.

The Prevention of Money Laundering Law 10/2010 requires banks and financial institutions to identify customers and beneficial owners. Where a healthcare-finance provider is subject to anti-money-laundering duties, remote identification may involve video verification, identity documents, electronic certificates or trusted databases. However, anti-money-laundering compliance does not automatically justify collecting all available medical information.

Payment services are governed principally by Royal Decree-Law 19/2018 and the EU payment-services framework. Strong customer authentication may be required when a patient pays a hospital bill, authorises an insurance premium or receives a healthcare reimbursement. Authentication should be based on independent factors such as a password, a possession-based device or biometric verification.

The Digital Operational Resilience Act also affects banks and insurers using healthcare-finance identity systems. Institutions must manage cyber risks, access controls, third-party technology providers, incident reporting, system testing and operational continuity. A failure in a hospital-payment identity platform may simultaneously create financial loss, privacy violations and disruption of essential healthcare.

The European Health Data Space Regulation introduces a broader European structure for electronic health-data access and exchange. Its importance for financial institutions is indirect but significant: banks and insurers must respect the distinction between healthcare data used for treatment and limited data used for payment, insurance or lawful secondary purposes.

Key Issues and Principles

Data minimisation

A healthcare-finance institution should collect only the information necessary for the particular transaction. For example, a bank may need confirmation that a treatment was authorised or that an insurance claim exists, but it normally does not need the medical diagnosis.

Separate identity from medical information

Identity verification should be technically separated from clinical records. A token, reference number or confirmation certificate may be preferable to transferring a full medical file. This reduces the consequences of identity theft and unauthorised internal access.

Biometric identification

Facial recognition, fingerprints and voice recognition may constitute biometric data used for uniquely identifying a person. Their use requires strict necessity, security, transparency and retention controls. Healthcare-finance providers should offer a reliable alternative where biometric authentication is inappropriate or inaccessible.

Consent and legal basis

Consent must be informed, specific and freely given. A patient should not be forced to consent to unrelated marketing or broad data sharing merely to obtain essential medical financing or insurance benefits. Processing may sometimes rely on contract, legal obligation or public interest rather than consent.

Confidentiality and access control

Employees of banks, insurers, hospitals and technology providers should have access only to the identity or financial data needed for their duties. Every access should be logged, reviewable and protected against internal misuse.

Automated decisions

If an insurer or lender uses digital identity, health information or algorithmic scoring to approve healthcare finance, the customer should receive meaningful information about the decision. Sensitive data should not be used to create unfair exclusions or discriminatory healthcare-finance conditions.

Case Laws

STC 292/2000, Spanish Constitutional Court. The Court recognised informational self-determination as an autonomous constitutional protection. It supports the principle that individuals must retain control over the collection and use of identity and health-related information.

STC 76/2019, Spanish Constitutional Court. The Court invalidated a legal provision allowing political profiling without sufficiently precise safeguards. Its wider lesson is that sensitive-data processing requires a clear legal basis, defined purposes and effective guarantees.

Google Spain SL v AEPD and Mario Costeja González, C-131/12, CJEU. The Court recognised the right to request delisting of certain personal information from search results. In healthcare finance, the judgment supports careful treatment of identity-linked information that could affect insurance, credit or access to services.

Lindqvist, C-101/01, CJEU. The Court treated information identifying individuals and describing their personal circumstances as personal data. The case illustrates that even apparently ordinary online information may become legally protected when linked to an identifiable person.

Z v Finland, European Court of Human Rights, 1997. The Court held that confidentiality of medical information is a fundamental element of private life. Disclosure of health information to financial institutions must therefore be narrowly justified and proportionate.

I v Finland, European Court of Human Rights, 2008. The Court found a violation where a healthcare institution failed to protect a patient’s medical records from unauthorised access. The case is highly relevant to banks and insurers connected to hospital systems because technical access controls are part of the legal duty of confidentiality.

M.S. v Sweden, European Court of Human Rights, 1997. The Court accepted that social and medical information requires strong protection and that disclosure must be justified by a pressing social need. Healthcare-finance data sharing must therefore remain limited and secure.

Conclusion

Spain’s digital identity framework for healthcare finance is built on eIDAS, GDPR, Organic Law 3/2018, patient-confidentiality legislation, anti-money-laundering rules, payment law and digital-resilience requirements. Financial institutions may verify identity electronically, but they must avoid treating medical information as ordinary banking data.

The legally safest model separates identity verification, payment authorisation and clinical information. It uses data minimisation, strong authentication, encryption, access logs, human review and alternative non-biometric methods. A bank or insurer that receives excessive medical information, permits unauthorised access or makes opaque health-based financial decisions may face data-protection penalties, contractual liability and constitutional claims.